About Styrax Pharma Private Limited
Data last updated:
Styrax Pharma Private Limited is a private limited company based in Vishakapatnam, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 10 July 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24230AP1995PTC098146. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹13.12 Cr. It was formerly known as Vaya Jayanthi Drugs Private Limited. It is led by directors including Suryadevara Venkateswara Rao (Managing Director) and Sreenath Suryadevara.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 27B J. N. Pharmacity Parawada Vishakapatnam, Andhra Pradesh, India – 531021.
As per the financials filed for FY 2024, the company reported a revenue of ₹260.24 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹9.16 Cr (net margin 3.5%) and EBITDA of ₹29.31 Cr (EBITDA margin 11.3%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years.
The company has about 260 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Styrax. As per MCA filings, the company has open charges of ₹187.82 Cr and satisfied charges of ₹163.68 Cr on record. Court records list 10 cases involving the company, including 2 filed by the company and 8 filed against it; 7 cases are pending. The company has 10 deals on record (6 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹15.8 Cr; the latest was in March 2021. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Embio Limited with revenue of ₹274.76 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website styraxpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No. 27B J. N. Pharmacity Parawada Vishakapatnam, Andhra Pradesh, India – 531021
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Styrax Pharma Private Limited
The main business activity of Styrax Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Styrax Pharma Private Limited FY 2025 filings available
Styrax Pharma Private Limited reported revenue of ₹260.24 Cr (up 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Styrax Pharma Private Limited
Revenue rose 4% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Styrax Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹29.31 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.16 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Styrax Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Styrax Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Styrax Pharma Private Limited
Styrax Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Embio Limited | ₹274.76 Cr (FY 2025) | •••• | •••• | 49.0% | •••• | Mumbai, Maharashtra, India |
| Sodium Metal Pvt Ltd | ₹273.32 Cr (FY 2023) | •••• | •••• | -11.0% | •••• | Baroda, Gujarat, India |
| Saraf Chemicals Private Limited | ₹271.96 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
| Venkata Narayana Active Ingredients Private Limited | ₹271.82 Cr (FY 2025) | •••• | •••• | 53.0% | •••• | Chennai, Tamil Nadu, India |
| Apothecon Pharmaceuticals Private Limited | ₹263.23 Cr (FY 2025) | •••• | •••• | 45.0% | •••• | Taluka Padra, Gujarat, India |
| Styrax Pharma Private Limited this company | ₹260.24 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Vishakapatnam, Andhra Pradesh, India |
| Rakshit Drugs Private Limited | ₹256.13 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Shaikpet, Telangana, India |
| Shodhana Laboratories Private Limited | ₹250.16 Cr (FY 2024) | •••• | •••• | -23.0% | •••• | Hyderabad, Telangana, India |
| East India Pharmaceutical Works Limited | ₹249.94 Cr (FY 2024) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Rakshit Pharmaceuticals Limited | ₹238.14 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Shaikpet, Telangana, India |
| Century Pharmaceuticals Limited | ₹234.99 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Baroda, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Styrax Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Styrax Pharma Private Limited
Styrax Pharma Private Limited is audited by V.M.G.K. MURTY & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V.M.G.K. MURTY & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Styrax Pharma Private Limited
Styrax Pharma has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreenath Suryadevara Also directs: Auctus Life Sciences LLP, Styrax Laboratories Private Limited | Director | 18 Apr 2019 | 7 Years 5 Months | Current |
| Lakshmi Devi Suryadevara | Director | 18 Apr 2019 | 7 Years 5 Months | Current |
| Suryadevara Venkateswara Rao | Managing Director | 23 Jun 2014 | 12 Years 3 Months | Current |
Ownership and Shareholding of Styrax Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Styrax Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Oct 2023 | Others | ₹45 Cr | Open |
| 29 Mar 2023 | Yes Bank Limited | ₹1.5 Cr | Open |
| 29 Mar 2023 | Yes Bank Limited | ₹20 Cr | Open |
| 23 Mar 2023 | Axis Bank Limited | ₹20.8 Cr | Open |
| 01 Mar 2023 | Others | ₹35 Cr | Open |
Total charge records: 26 View all charges
Deals & Funding of Styrax Pharma Private Limited
Styrax Pharma Private Limited has 10 deals on record (6 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹15.8 Cr; the latest was in March 2021.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Aurore Life Sciences Private Limited |
| Jul 2017 | Rights issue | ₹17.71 Cr | Investors: Aurore Life Sciences Private Limited |
| Nov 2015 | Funding round | ₹14 Cr | Investors: 4 individuals |
| Oct 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
Full deal history
All 10 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Styrax Pharma Private Limited
Styrax Pharma Private Limited has 10 court cases on record: 2 filed by Styrax Pharma, 8 filed against it. 7 cases are pending and 3 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 8 | 7 |
| High courts | 2 | 0 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed against the company by R.R.Enterprises Pvt Ltd | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by Karnataka Chemical Industries | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed against the company by Earthchem International Trade | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed against the company by Greenfy India | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed against the company by M/S.Greenfy India | Pending |
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Styrax Pharma Private Limited
Styrax Pharma operates one associated brand: Styrax. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer & supplier of active pharmaceutical ingredients and intermediates | styraxpharma.com |
Employees and EPFO Compliance at Styrax Pharma Private Limited
Styrax Pharma Private Limited has a workforce of 260 employees as of Dec 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Styrax Pharma Private Limited
Styrax Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24230AP1995PTC098146, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230AP1995PTC098146 | Current |
| U24230TG1995PTC020995 | Previous |
| U24230AP1995PTC020995 | Previous |
Recent Activity on Styrax Pharma Private Limited
Styrax Pharma Private Limited has 11 board changes on record since 2008: 3 appointments and 8 cessations. The latest: Sreenath Suryadevara ceased to be Additional Director on 30 Sep 2019.
60 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Styrax Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Styrax Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Styrax Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Styrax Pharma Private Limited
Styrax Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Styrax Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Styrax Pharma Private Limited
Styrax Pharma is an active private limited company based in Vishakapatnam, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 10 July 1995 (31+ years old) and is registered under CIN U24230AP1995PTC098146.
Styrax Pharma reported revenue of ₹260.24 Cr for FY 2024 (up 4% YoY).
Styrax Pharma has 3 current directors:
- Suryadevara Venkateswara Rao - Managing Director
- Sreenath Suryadevara - Director
- Lakshmi Devi Suryadevara - Director
Styrax Pharma reported a net profit of ₹9.16 Cr (net margin 3.5%) and EBITDA of ₹29.31 Cr (EBITDA margin 11.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Styrax Pharma is -3% over three years. In the latest year (FY 2024) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.
No. Styrax Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Styrax Pharma is U24230AP1995PTC098146. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Styrax Pharma has 10 court cases on record: 2 filed by the company and 8 filed against it. 7 are pending. Most are in the district courts.
Styrax Pharma was incorporated on 10 July 1995, making it 31+ years old. It is registered with the Registrar of Companies, Vijayawada.
Styrax Pharma has 10 deals on record (6 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹15.8 Cr; the latest was in March 2021.
The peers of Styrax Pharma by revenue are Embio Limited, Sodium Metal Pvt Ltd, Saraf Chemicals Private Limited, Venkata Narayana Active Ingredients Private Limited, Apothecon Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (API Manufacturers).